Ken Griffin Catalyst Biosciences, Inc. Transaction History

Citadel Advisors LLC

$483 Billion
Q2 2024

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	BUY	$0.33 - $0.65 $15,828 - $31,177	47,966 New	47,966 $23,000
Q1 2023 May 15, 2023	SELL	$0.19 - $0.64 $56,213 - $189,351	-295,861 Reduced 94.91%	15,855 $3,000
Q4 2022 Feb 14, 2023	BUY	$0.49 - $0.57 $122,754 - $142,795	250,519 Added 409.36%	311,716 $165,000
Q3 2022 Nov 14, 2022	SELL	$0.49 - $1.95 $7,194 - $28,631	-14,683 Reduced 19.35%	61,197 $31,000
Q2 2022 Aug 15, 2022	BUY	$0.36 - $1.78 $15,971 - $78,967	44,364 Added 140.77%	75,880 $135,000
Q4 2021 Feb 14, 2022	SELL	$0.91 - $4.16 $30,842 - $140,994	-33,893 Reduced 51.82%	31,516 $28,000
Q3 2021 Nov 15, 2021	BUY	$3.78 - $5.18 $79,716 - $109,241	21,089 Added 47.58%	65,409 $268,000
Q4 2020 Feb 16, 2021	BUY	$4.55 - $7.29 $60,965 - $97,678	13,399 Added 43.33%	44,320 $280,000
Q3 2020 Nov 16, 2020	SELL	$4.22 - $6.04 $1.62 Million - $2.31 Million	-382,941 Reduced 92.53%	30,921 $133,000
Q2 2020 Aug 14, 2020	SELL	$3.76 - $8.01 $778,244 - $1.66 Million	-206,980 Reduced 33.34%	413,862 $2.43 Million
Q1 2020 May 15, 2020	BUY	$3.5 - $8.51 $859,810 - $2.09 Million	245,660 Added 65.48%	620,842 $2.71 Million
Q4 2019 Feb 14, 2020	BUY	$4.52 - $7.91 $358,738 - $627,792	79,367 Added 26.83%	375,182 $2.56 Million
Q3 2019 Nov 14, 2019	BUY	$4.91 - $9.31 $1.18 Million - $2.25 Million	241,251 Added 442.14%	295,815 $1.45 Million
Q2 2019 Aug 14, 2019	BUY	$7.08 - $10.6 $26,896 - $40,269	3,799 Added 7.48%	54,564 $402,000
Q1 2019 May 15, 2019	SELL	$7.67 - $9.96 $182,285 - $236,709	-23,766 Reduced 31.89%	50,765 $0
Q4 2018 Feb 14, 2019	BUY	$6.59 - $11.28 $202,438 - $346,510	30,719 Added 70.12%	74,531 $588,000
Q3 2018 Nov 13, 2018	BUY	$9.35 - $12.44 $274,824 - $365,648	29,393 Added 203.85%	43,812 $0
Q2 2018 Aug 10, 2018	BUY	$9.11 - $28.88 $131,357 - $416,420	14,419 New	14,419 $0

Others Institutions Holding CBIO

# of Institutions

Shares Held

215

Call Options Held

Put Options Held

American Portfolios Advisors Holbrook, NY

215
Shares

$0
0.0% of portfolio

View Full List

About CATALYST BIOSCIENCES, INC.

Ticker CBIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 31,477,100
Description
Catalyst Biosciences, Inc., a clinical-stage biopharmaceutical company, focuses on developing protease product candidates in the fields of hemostasis and complement regulation. The company's protease engineering platform creates improved or novel molecules to treat diseases that result from dysregulation of the complement system. It develops CB ...

More about CBIO

Track Ken Griffin's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.

Account